DBV TECHNOLOGIES (EPA:DBV)

BRIEF

published on 10/06/2025 at 23:07, 1 month 29 days ago

DBV Technologies Raises $30 Million Through Nasdaq ATM Program

Nasdaq Capital Increase DBV Technologies ATM Program ADS Sale
PRESS RELEASE

published on 10/06/2025 at 23:02, 1 month 29 days ago

DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
DBV Technologies announces sale of $30 million of ADSs through its At-The-Market (ATM) program on Nasdaq. New ordinary shares will be issued to Invus. ADSs and Ordinary Shares represent 5 Ordinary Shares of the Company each

Ordinary Shares Nasdaq Ads DBV Technologies At-the-market Program
BRIEF

published on 09/18/2025 at 22:35, 2 months 16 days ago

Board Member Resigns from DBV Technologies

Resignation Biopharmaceutical Board Member DBV Technologies Viaskin Peanut
PRESS RELEASE

published on 09/18/2025 at 22:30, 2 months 16 days ago

DBV Technologies Announces Resignation of Board Member
DBV Technologies announces the resignation of Board Member Daniel Soland. The company focuses on developing treatment options for food allergies with VIASKIN patch technology

Resignation Board Member DBV Technologies Food Allergies VIASKIN Patch
BRIEF

published on 09/03/2025 at 22:35, 3 months 1 day ago

DBV Technologies at the HC Wainwright Global Investment Conference

DBV Technologies Food Allergies HC Wainwright Lecture Epicutaneous Immunotherapy VIASKIN® Patch
BRIEF

published on 08/01/2025 at 22:10, 4 months 3 days ago

DBV Technologies: Share Capital Balance Sheet as of July 31, 2025

Share Capital Voting Rights Actions DBV Technologies NYSE Euronext Paris
PRESS RELEASE

published on 08/01/2025 at 22:05, 4 months 3 days ago

Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2025
Press release on the total number of voting rights and shares of the Company as of July 31, 2025, in compliance with Article 223-16 of the AMF General Regulations

Voting Rights Shares AMF General Regulations NYSE Euronext Paris July 31, 2025
BRIEF

published on 07/29/2025 at 22:22, 4 months 6 days ago

DBV Technologies Files 2025 Half-Year Report

Biopharmaceuticals AMF Filing VIASKIN® Patch DBV Half-Year Report Food Allergy Treatment
PRESS RELEASE

published on 07/29/2025 at 22:17, 4 months 6 days ago

DBV Technologies announces filing of 2025 Half-Year Report ? Conditions for accessing or consulting the Report
DBV Technologies files 2025 Half-Year Report with market authority AMF, focusing on food allergy treatment options. Reports available on company & AMF websites, accessible by mail or email

Clinical-Stage Biopharmaceutical DBV Technologies Food Allergies 2025 Half-Year Report IMT
BRIEF

published on 07/29/2025 at 22:13, 4 months 6 days ago

DBV Technologies Posts Financial Results for H1 2025

Research And Development Operating Income DBV Technologies Viaskin Peanut Financial Results 2025

Published on 12/05/2025 at 02:35, 7 hours 1 minute ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 7 hours 6 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 8 hours 36 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 31 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 10 hours 36 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

Published on 12/05/2025 at 09:05, 31 minutes ago

Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 09:00, 35 minutes ago

Original-Research: DEMIRE AG (von NuWays AG): BUY
Published on 12/05/2025 at 09:00, 36 minutes ago

SPECTRIS PLC - Removal
Published on 12/05/2025 at 09:00, 36 minutes ago

Official List Notice
Published on 12/05/2025 at 09:00, 36 minutes ago

Petershill Partners plc - Removal

View all EQS

Published on 12/05/2025 at 08:45, 51 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 15 hours 36 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 15 hours 51 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 15 hours 52 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 2 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE

News